Vivani Medical, Inc. (VANI) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Vivani Medical, Inc. (VANI) stock forecast summary
On Oct. 16, 2026, VANI is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
Vivani Medical, Inc. is a small-cap company with a market capitalization of $104M. It ranks number 13 by market capitalization among the 30 Electromedical & Electrotherapeutic Apparatus issuers in our coverage with a current forecast.
For VANI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 12.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 8.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, VANI included.
Follow VANI freeVANI price chart and AI forecast
How VANI ranks among 5172 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Vivani Medical, Inc. (VANI) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Electromedical & Electrotherapeutic Apparatus peers listed below that report each metric.
Valuation & Market
| Metric | VANI | Rank |
|---|---|---|
| Market Cap | $104M | 13/30 |
| P/B Ratio | 5.47x | 7/23 |
| EPS | $-0.38 | – |
| Book Value/Share | $0.21 | – |
| FCF/Share | $-0.29 | – |
Profitability & Margins
| Metric | VANI | Rank |
|---|---|---|
| ROE | -138.7% | 17/19 |
| ROA | -63.2% | 18/24 |
| ROIC | -77.8% | 22/23 |
| Tax Rate | -0.0% | – |
Financial Health
| Metric | VANI | Rank |
|---|---|---|
| Current Ratio | 3.25x | 12/30 |
| D/E Ratio | 1.20x | 8/25 |
| Financial Leverage | 2.20x | 8/25 |
| Interest Coverage | -1164.2x | 30/30 |
| Working Capital | $15M | 16/29 |
Cash Flow
| Metric | VANI | Rank |
|---|---|---|
| Operating Cash Flow | -$25M | 26/30 |
| Free Cash Flow | -$26M | 10/14 |
| Capital Spending | -$1M | 8/14 |
Income Statement
| Metric | VANI | Rank |
|---|---|---|
| Operating Income | -$27M | 25/30 |
| Net Income | -$26M | 20/24 |
| R&D Expense | $18M | 10/28 |
Dividend & Shareholder Information
| Metric | VANI | Rank |
|---|---|---|
| Shares Outstanding | 90M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $22M | 52.0% of assets |
| Cash & Short-term Investments | $20M | 47.8% of assets |
| Total Liabilities | $23M | 54.5% of assets |
| Short-term Debt | $5M | 13.1% of assets |
VANI quarterly financials and insider trading
Vivani Medical, Inc. (VANI) industry peers
Companies classified under the same SEC industry code as Vivani Medical, Inc. (Electromedical & Electrotherapeutic Apparatus): 32 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| VANI Vivani Medical, Inc. | ▶ | $104M |
| MDT Medtronic Plc | ▼ | $121.20B |
| ITGR Integer Holdings Corp | ▼ | $4.31B |
| LIVN Livanova Plc | ▼ | $4.27B |
| TMDX Transmedics Group, Inc. | ▲ | $2.45B |
| BLFS Biolife Solutions Inc | ▶ | $1.89B |
| AXGN Axogen, Inc. | ▲ | $1.86B |
| CNMD Conmed Corp | ▼ | $1.40B |
| CBLL Ceribell, Inc. | ▲ | $961M |
| INMD Inmode Ltd. | ▼ | $814M |
| CV Capsovision, Inc | ▶ | $323M |
| ELMD Electromed, Inc. | ▼ | $229M |
| FOCL Edap Tms Sa | ▲ | $153M |
| STXS Stereotaxis, Inc. | ▶ | $101M |
| NRXS Neuraxis, Inc | ▲ | $97M |
| HYPR Hyperfine, Inc. | ▲ | $77M |
| OM Outset Medical, Inc. | ▲ | $77M |
| ECOR Electrocore, Inc. | ▲ | $71M |
| POSC Positron Corp | ▲ | $53M |
| VASO Vaso Corp | ▲ | $51M |
| POCI Precision Optics Corporation, Inc. | ▲ | $48M |
| QTI Qt Imaging Holdings, Inc. | ▶ | $35M |
| ITOC Itonic Holdings Ltd | ▼ | $29M |
| GTHP Guided Therapeutics Inc | ▲ | $18M |
| IRIX Iridex Corp | ▲ | $14M |
| NDRA Endra Life Sciences Inc. | ▶ | $7M |
| ADMT Adm Tronics Unlimited, Inc. | ▶ | $3M |
| NXL Nexalin Technology, Inc. | ▼ | $2M |
| NUWE Nuwellis, Inc. | ▼ | $2M |
| ESMC Escalon Medical Corp | ▲ | $1M |
| HCIL Hongchang International Co., Ltd | ▼ | N/A |
| YBGJ Yubo International Biotech Ltd | ▶ | N/A |
Where VANI sits on the market map
Vivani Medical, Inc. (VANI) stock news
Loading...
Vivani Medical, Inc. (VANI) stock forecast FAQ
What is the Vivani Medical, Inc. (VANI) stock forecast?
On Oct. 16, 2026, VANI is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
How accurate are Vivani Medical, Inc. stock predictions?
For VANI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 12.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 8.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Vivani Medical, Inc. forecasts updated?
Vivani Medical, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Vivani Medical, Inc.'s industry peers?
32 issuers in our coverage, VANI included, share the SEC industry code Electromedical & Electrotherapeutic Apparatus. The largest are: Medtronic Plc (MDT), Integer Holdings Corp (ITGR), Livanova Plc (LIVN), Transmedics Group, Inc. (TMDX), Biolife Solutions Inc (BLFS), Axogen, Inc. (AXGN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.